vs
Side-by-side financial comparison of Global-E Online Ltd. (GLBE) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Global-E Online Ltd. is the larger business by last-quarter revenue ($625.5M vs $346.4M, roughly 1.8× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 0.9%, a 27.2% gap on every dollar of revenue.
Global-E Online Ltd. operates a leading cross-border e-commerce enablement platform that helps direct-to-consumer brands and retail enterprises expand their international sales reach. It offers end-to-end services including localized checkout, payment processing, customs clearance, logistics coordination, and duty calculation, serving clients across North America, Europe, and the Asia-Pacific region.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
GLBE vs HAE — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $625.5M | $346.4M |
| Net Profit | $5.8M | $97.3M |
| Gross Margin | 45.0% | 57.2% |
| Operating Margin | 1.3% | 36.1% |
| Net Margin | 0.9% | 28.1% |
| Revenue YoY | — | 4.8% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | — | $339.0M | ||
| Q3 25 | $625.5M | $327.3M | ||
| Q2 25 | $404.8M | $321.4M | ||
| Q1 25 | $189.9M | $330.6M | ||
| Q4 24 | — | $348.5M | ||
| Q3 24 | $489.9M | $345.5M | ||
| Q2 24 | $313.9M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | — | $44.7M | ||
| Q3 25 | $5.8M | $38.7M | ||
| Q2 25 | $-7.4M | $34.0M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $-77.1M | $33.8M | ||
| Q2 24 | $-54.5M | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | 45.0% | 59.5% | ||
| Q2 25 | 44.9% | 59.8% | ||
| Q1 25 | 44.3% | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | 45.1% | 54.2% | ||
| Q2 24 | 44.8% | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | — | 19.9% | ||
| Q3 25 | 1.3% | 17.9% | ||
| Q2 25 | -2.1% | 16.8% | ||
| Q1 25 | -10.1% | 21.6% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | -14.9% | 15.0% | ||
| Q2 24 | -16.6% | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | — | 13.2% | ||
| Q3 25 | 0.9% | 11.8% | ||
| Q2 25 | -1.8% | 10.6% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -15.7% | 9.8% | ||
| Q2 24 | -17.4% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.95 | ||
| Q3 25 | — | $0.81 | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $1.17 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $0.66 | ||
| Q2 24 | — | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $251.4M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $933.0M | $796.3M |
| Total Assets | $1.3B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | — | $363.4M | ||
| Q3 25 | $251.4M | $296.4M | ||
| Q2 25 | $205.2M | $292.9M | ||
| Q1 25 | $207.7M | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | $207.3M | $299.3M | ||
| Q2 24 | $229.8M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | — | $911.5M | ||
| Q3 25 | $933.0M | $849.2M | ||
| Q2 25 | $909.1M | $882.3M | ||
| Q1 25 | $884.3M | $820.8M | ||
| Q4 24 | — | $906.9M | ||
| Q3 24 | $869.4M | $878.9M | ||
| Q2 24 | $878.7M | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.3B | $2.4B | ||
| Q2 25 | $1.2B | $2.5B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $1.2B | $2.5B | ||
| Q2 24 | $1.1B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | — | $209.9M |
| FCF MarginFCF / Revenue | — | 60.6% |
| Capex IntensityCapex / Revenue | — | 9.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | — | $93.6M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $43.8M | ||
| Q3 24 | — | $48.8M | ||
| Q2 24 | — | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLBE
Segment breakdown not available.
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
